I think Replicel is probably toast but I’m kind of surprised we aren’t hearing something from Follica. I can’t believe that nobody has any info. They used to be in the lead among the new revolutionary treatment companies but if they are not doing anything then they have allowed themselves to lose the lead. It looks like Allergan’s bimatoprost and the Aderans treatment are not the front-runners. You can’t tell what’s going on with them because they aren’t saying anything.
» I think Replicel is probably toast but I’m kind of surprised we aren’t
» hearing something from Follica. I can’t believe that nobody has any info.
» They used to be in the lead among the new revolutionary treatment companies
» but if they are not doing anything then they have allowed themselves to
» lose the lead. It looks like Allergan’s bimatoprost and the Aderans
» treatment are not the front-runners. You can’t tell what’s going on with
» them because they aren’t saying anything.
The above post is messed up. I meant to say:
I think Replicel is probably toast but I’m kind of surprised that we aren’t hearing something from Follica. I can’t believe that nobody has any info. Follica used to be in the lead among the new revolutionary treatments but if they have allowed themselves to be overtaken. It looks like Allergan’s bimatoprost and the Aderan treatment are now the front-runners. You can’t tell what’s going on with Follica because they aren’t saying anything.